305 related articles for article (PubMed ID: 28003592)
41. Clinical significance and phylogenetic background of extended spectrum β-lactamase producing Escherichia coli isolates from extra-intestinal infections.
Chakraborty A; Adhikari P; Shenoy S; Saralaya V
J Infect Public Health; 2015; 8(3):248-53. PubMed ID: 25466593
[TBL] [Abstract][Full Text] [Related]
42. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
Abrar S; Vajeeha A; Ul-Ain N; Riaz S
Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
[TBL] [Abstract][Full Text] [Related]
43. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
44. Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from pets in France.
Dahmen S; Haenni M; Châtre P; Madec JY
J Antimicrob Chemother; 2013 Dec; 68(12):2797-801. PubMed ID: 23852541
[TBL] [Abstract][Full Text] [Related]
45. Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.
Timofte D; Maciuca IE; Williams NJ; Wattret A; Schmidt V
Microb Drug Resist; 2016 Oct; 22(7):609-615. PubMed ID: 27314838
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
[TBL] [Abstract][Full Text] [Related]
48. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
[TBL] [Abstract][Full Text] [Related]
49. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
Suzuki S; Shibata N; Yamane K; Wachino J; Ito K; Arakawa Y
J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
[TBL] [Abstract][Full Text] [Related]
50. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
[TBL] [Abstract][Full Text] [Related]
51. Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan.
Huang IF; Lee WY; Wang JL; Hung CH; Hu HH; Hung WY; Hung YJ; Chen WC; Shen YT; Cheng MF
BMC Gastroenterol; 2018 Jun; 18(1):86. PubMed ID: 29907090
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli Strains Isolated from Multiple Rivers in Southern Taiwan.
Chen PA; Hung CH; Huang PC; Chen JR; Huang IF; Chen WL; Chiou YH; Hung WY; Wang JL; Cheng MF
Appl Environ Microbiol; 2016 Jan; 82(6):1889-1897. PubMed ID: 26773082
[TBL] [Abstract][Full Text] [Related]
53. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011.
Brolund A; Edquist PJ; Mäkitalo B; Olsson-Liljequist B; Söderblom T; Wisell KT; Giske CG
Clin Microbiol Infect; 2014 Jun; 20(6):O344-52. PubMed ID: 24118431
[TBL] [Abstract][Full Text] [Related]
55. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
[TBL] [Abstract][Full Text] [Related]
56. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
57. Prevalence, phylogeny, and antimicrobial resistance of Escherichia coli pathotypes isolated from children less than 5 years old with community acquired- diarrhea in Upper Egypt.
Khairy RMM; Fathy ZA; Mahrous DM; Mohamed ES; Abdelrahim SS
BMC Infect Dis; 2020 Dec; 20(1):908. PubMed ID: 33256619
[TBL] [Abstract][Full Text] [Related]
58. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
59. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001-2002.
Severin JA; Lestari ES; Kloezen W; Lemmens-den Toom N; Mertaniasih NM; Kuntaman K; Purwanta M; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
Trop Med Int Health; 2012 Apr; 17(4):455-61. PubMed ID: 22248076
[TBL] [Abstract][Full Text] [Related]
60. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
Gonçalves LF; de Oliveira Martins-Júnior P; de Melo ABF; da Silva RCRM; de Paulo Martins V; Pitondo-Silva A; de Campos TA
J Glob Antimicrob Resist; 2016 Sep; 6():1-4. PubMed ID: 27530830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
